ZyVersa gains FDA approval for emergency use of VAR 200 in a rare kidney disease case; stock jumps on high trading volume and ...

Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.

Medical device steriliser Nanosonics is pushing for stronger sales of its flagship device Trophon, ahead of the release of an ...

ApoCII amyloidosis, resulting from abnormal organ deposition of toxic fibrillar amyloid proteins, is an ultra-rare condition that mostly affects the kidneys and manifests with protein spillage into th ...

Coleman was diagnosed with focal segmental glomerulosclerosis, a degenerative kidney disease which causes irreversible ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Japan Dr Akira Tamaoka, Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, 1–1–1 Tennoudai, ...